News from Althea
ACNR announces new partnership with Taylor & Francis
20% book discount offer from Taylor & Francis
Christchurch Group announces appointment of Donald Muir as Non-Executive Chairman
News from The Christchurch Group
NHS England will fund everolimus for TSC-related refractory epilepsy
News from the Tuberous Sclerosis Association
Viewpoints: News from the ILAE British Chapter Annual Scientific Meeting
Download our 8 page newsletter, produced in association with LivaNova
People in Scotland get access to new first-in-class treatment Ocrevus®▼(ocrelizumab) for multiple sclerosis
News from industry: Roche
Encephalitis Society Silver Jubilee PhD Fellowship 2019 – Host academic Institution sought
The Encephalitis Society are seeking an academic institution to host the 2019 Encephalitis Society PhD Fellowship. Deadline: Monday, December 31, 2018
Emgality® (galcanezumab) Receives European Commission Approval for the Prophylaxis of Migraine in Adults
New migraine treatment from Lilly receives approval from European Commission
Meeting on Abeta Oligomers in Alzheimer’s Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
Industry news from AC Immune SA